Venkata Maidhar Yenugonda, M.Phil, Ph.D., Associate Professor in the Department of Translational Neurosciences, and Director of Drug Discovery and Nanomedicine Research Program at the Saint John’s Cancer Institute, published the article, Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform: State of the Art, Emerging Technologies, and Perspectives, in the International Journal of Nanomedicine.

View Dr. Yenugonda’s video abstract to learn about Lipid–polymer hybrid nanoparticles (LPHNPs) and the recent key advancements in its design, synthesis, and bioactivity evaluation for future clinical possibilities.